Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Broadway Financial (BYFC) Loans - Loss Allowance: 2015-2025

Historic Loans - Loss Allowance for Broadway Financial (BYFC) over the last 10 years, with Mar 2025 value amounting to $8.8 million.

  • Broadway Financial's Loans - Loss Allowance rose 16.18% to $8.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $8.8 million, marking a year-over-year increase of 16.18%. This contributed to the annual value of $8.4 million for FY2024, which is 10.34% up from last year.
  • Latest data reveals that Broadway Financial reported Loans - Loss Allowance of $8.8 million as of Q1 2025, which was up 4.45% from $8.4 million recorded in Q4 2024.
  • Broadway Financial's Loans - Loss Allowance's 5-year high stood at $8.8 million during Q1 2025, with a 5-year trough of $3.0 million in Q2 2022.
  • Moreover, its 3-year median value for Loans - Loss Allowance was $7.6 million (2023), whereas its average is $7.7 million.
  • In the last 5 years, Broadway Financial's Loans - Loss Allowance declined by 10.13% in 2022 and then spiked by 135.31% in 2023.
  • Broadway Financial's Loans - Loss Allowance (Quarterly) stood at $3.4 million in 2021, then climbed by 29.40% to $4.4 million in 2022, then skyrocketed by 73.50% to $7.6 million in 2023, then grew by 10.34% to $8.4 million in 2024, then rose by 16.18% to $8.8 million in 2025.
  • Its Loans - Loss Allowance stands at $8.8 million for Q1 2025, versus $8.4 million for Q4 2024 and $8.5 million for Q3 2024.